| Literature DB >> 35453218 |
Claudia Hess1, Salome Troxler1, Delfina Jandreski-Cvetkovic1, Angelika Zloch1,2, Michael Hess1.
Abstract
The present study investigated the resistance characteristics of E. coli isolates originating from 18 organic laying hen flocks. E. coli was isolated from different organs at three different time points, resulting in 209 E. coli isolates. The antibiotic susceptibility was determined by applying a microdilution assay. General, a high resistance rate was found. The antibiotic susceptibility was independent from the presence of pathological lesions, the isolation site, or the affiliation to a pathogenic serogroup. The majority of the isolates proved to be multi-drug-resistant (95.70%), of which 36.84% could be categorized as extensively drug-resistant. All isolates were resistant to oxacillin and tylosin. Resistance rates to amoxicillin (67.94%), cefoxitin (55.98%), ceftazidime (82.30%), colistin (73.68%), nalidixic acid (91.87%), streptomycin (42.58%), tetracycline (53.59%), and sulfamethoxazole (95.22%) were high. None of the isolates revealed pan-drug-resistance. A great heterogeneity of resistance profiles was found between isolates within a flock or from different organs of the same bird, even when isolates originated from the same organ. An increase in antimicrobial resistance was found to be correlated with the age of the birds. The fact, that no antibiotic treatment was applied except in two flocks, indicates that resistant bacteria circulating in the environment pose a threat to organic systems.Entities:
Keywords: E. coli; MDR; PDR; XDR; antibiotics; microdilution; organic laying hens; poultry; resistant; susceptibility
Year: 2022 PMID: 35453218 PMCID: PMC9027956 DOI: 10.3390/antibiotics11040467
Source DB: PubMed Journal: Antibiotics (Basel) ISSN: 2079-6382
Occurrence of pathological lesions in ovary/oviduct.
| Flock No. | Pathological Lesions in Ovary/Oviduct | ||
|---|---|---|---|
| S1 | S2 | S3 | |
| 1 | 0/5 b | 2/5 | 0/5 |
| 2 | 0/5 | 0/5 | 0/5 |
| 3 | 0/5 | 0/5 | 2/5 |
| 4 | 0/5 | 1/5 | 4/5 |
| 5 | 0/5 | 0/5 | 0/5 |
| 6 | 0/5 | 0/5 | 0/5 |
| 7 | 0/5 | 0/5 | 1/5 |
| 8 | 0/5 | 0/5 | 0/5 |
| 9 | 0/5 | 0/5 | 1/5 |
| 10 | 0/5 | 0/5 | 2/5 |
| 11 | 0/5 | 0/5 | 0/5 |
| 12 | 0/5 | 0/5 | 4/5 |
| 13 a | 0/5 | 0/5 | 0/5 |
| 14 a | 0/5 | 2/5 | 1/5 |
| 15 | 0/5 | 0/5 | 2/5 |
| 16 | 0/5 | 0/5 | 2/5 |
| 17 | 0/5 | 0/5 | 4/5 |
| 18 | 0/5 | 0/5 | 0/5 |
a flock no. 13 and 14 originated from the same farm; b number of birds with pathological lesions in ovary and oviduct/number of necropsied birds.
Number of E. coli isolates per organ isolated at S1, S2, and S3, with corresponding serogroup in brackets.
| Flock | Time Point | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2 | 3 | |||||||||||||
| Heart | Liver | Lung | Ovary | Oviduct | Heart | Liver | Lung | Ovary | Oviduct | Heart | Liver | Lung | Ovary | Oviduct | |
| 1 | 5 (5 × O1) | 1 | 1 | 1 (O2) | 1 | 1 | 4 | ||||||||
| 2 | 4 | 4 (1 × O1) | 1 (O1) | 4 (3 × O1) | |||||||||||
| 3 | 1 | 4 | |||||||||||||
| 4 | 1 | 1 | 1 | 2 | 3 | 9 | 6 | ||||||||
| 5 | 2 | 2 | 6 | 4 (1 × O1) | 3 | ||||||||||
| 6 | 2 | 3 | 3 (1 × O1) | ||||||||||||
| 7 | 2 | 2 | 3 (1 × O1) | ||||||||||||
| 8 | 3 | 3 | 3 | 6 | 3 | ||||||||||
| 9 | 1 | 3 (1 × O1) | 1 (O1) | 1 | 1 | 5 (2 × O1) | 2 | ||||||||
| 10 | 5 (4 × O1) | 2 (1 × O1) | 2 (2 × O1) | ||||||||||||
| 11 | 5 (4 × O1) | 2 | 1 | ||||||||||||
| 12 | 4 (1 × O1) | 1 | 4 | 1 | 1 | 2 | 1 | 1 (O2) | |||||||
| 13 | 2 (1 × O2) | 2 | 1 | 3 | 1 | ||||||||||
| 14 | 3 (2 × O2) | 6 | 3 | 3 | |||||||||||
| 15 | 2 | 3 | 5 | ||||||||||||
| 16 | 3 | 3 | |||||||||||||
| 17 | 15 | ||||||||||||||
| 18 | 3 | ||||||||||||||
| Total | 3 | 2 | 8 | 23 | 11 | 3 | 4 | 4 | 40 | 19 | 0 | 12 | 7 | 49 | 24 |
Antimicrobial substances and concentrations used for AMR testing, respective minimal inhibitory concentration for resistance (MIC, µg/mL), and the percentage of resistant isolates based on the given MIC.
| Class | Antimicrobial Substance | Concentrations (µg/mL) | MIC (µg/mL) | % of Resistant Isolates (n = 209) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Penicillin, penicillin combination | Amoxicillin | 4 | 8 | 16 | 32 | ≥32 | 67.94% | ||||||
| Amoxicillin/clavulanate | 4/2 | 8/4 | 16/8 | 32/16 | ≥32/16 | 2.39% | |||||||
| Ampicillin | 0.25 | 0.5 | 1 | 2 | 4 | 8 | 16 | >16 | 17.70% | ||||
| Oxacillin | 0.25 | >0.2 | 100.00% | ||||||||||
| Cephalosporin | Cefazolin (1st generation) | 2 | 4 | >4 | 20.10% | ||||||||
| Cefoxitin (2nd generation) | 4 | >4 | 55.98% | ||||||||||
| Cefotaxim (3rd generation) | 0.25 | 0.5 | 1 | 2 | 4 | 8 | 16 | 32 | ≥4 | 9.57% | |||
| Ceftazidim (3rd generation) | 0.25 | 0.5 | 1 | 2 | 4 | 8 | 16 | 32 | ≥16 | 82.30% | |||
| Chloramphenicol | Chloramphenicol | 4 | 8 | 16 | 32 | ≥32 | 33.97% | ||||||
| Polypeptide | Colistin | 0.0313 | 0.063 | 0.13 | 0.25 | 0.5 | 1 | 2 | 4 | 8 | 16 | ≥4 | 73.68% |
| Quinolone | Enrofloxacin | 0.125 | 0.25 | 0.5 | 1 | 2 | ≥2 | 11.96% | |||||
| Nalidixic acid | 4 | 8 | 16 | 32 | 64 | >64 | 91.87% | ||||||
| Aminoglycoside | Gentamicin | 1 | 2 | 4 | 8 | 16 | ≥8 | 6.22% | |||||
| Neomycin | 4 | 8 | 16 | 32 | ≥16 | 11.48% | |||||||
| Streptomycin | 8 | 16 | 32 | 64 | ≥32 | 42.58% | |||||||
| Carbapenem | Imipenem | 1 | 2 | 4 | ≥4 | 9.09% | |||||||
| Tetracycline | Tetracycline | 0.25 | 0.5 | 1 | 2 | 4 | 8 | 16 | ≥16 | 53.59% | |||
| Diaminopyrimidine, sulfamethoxazole, and combinations | Trimethoprim | 8 | 16 | ≥16 | 37.80% | ||||||||
| Sulfamethoxazole | 256 | 512 | ≥512 | 95.22% | |||||||||
| Trimethoprim/sulfamethoxazole | 0.5/9.5 | 1/19 | 2/38 | 4/76 | ≥4/76 | 14.83% | |||||||
| Macrolide | Tylosin | 1 | 2 | 4 | 8 | 16 | ≥16 | 100.00% | |||||
Figure 1Categorization of the 209 E. coli isolates investigated based on their antimicrobial resistance profiles into multidrug resistant (MDR) and non-MDR, and their further subdivision into extensively drug-resistant (XDR) and non-XDR Not MDR—isolates without multidrug resistance; MDR—isolates with multidrug resistance; not XDR—isolates without extensive drug resistance; XDR—isolates with extensive drug resistance.
Differences in antimicrobial profiles of E. coli isolates within a flock, between organs of the same bird, and within the same organ, exemplarily shown for flock 6 (excluding oxacillin and tylosin). Results of susceptibility testing are given as susceptible (S), resistant (R), and intermediate (I).
| Time Point | Organ | Antimicrobials | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AMC | AMP | AMX | CAZ | CEZ | CMP | COL | COX | CTX | ENR | GEN | IMP | NAL | NEO | SMO | STR | T/S | TET | TRP | ||
| 1 | oviduct | S | R | R | R | I | S | S | R | S | I | S | R | R | S | R | I | S | R | S |
| 1 | oviduct | S | S | S | R | I | S | R | S | S | I | S | S | R | S | S | R | S | S | S |
| 1 | oviduct | S | S | S | R | S | S | R | S | S | I | S | S | R | S | R | I | S | S | S |
| 1 | oviduct | S | S | S | S | I | S | S | R | S | R | R | R | R | R | R | R | S | I | S |
| 1 | oviduct | S | S | S | S | I | S | S | S | S | S | S | S | S | S | R | S | S | S | S |
| 2 | heart | S | S | R | R | S | S | R | R | S | I | S | S | R | S | R | S | R | R | R |
| 2 | lung | S | S | R | R | S | I | R | R | S | I | S | S | R | I | R | I | R | R | R |
| 2 | ovary | S | I | R | R | S | R | R | R | S | I | S | S | R | I | R | R | R | R | R |
| 2 | ovary | S | S | I | R | S | R | R | S | S | I | S | S | R | I | R | S | R | R | R |
| 2 | ovary | S | S | R | R | S | I | R | R | S | I | S | S | R | S | R | I | S | R | R |
| 2 | oviduct | S | S | S | R | S | S | R | R | R | I | I | R | R | S | R | R | R | R | R |
| 3 | liver | S | S | R | R | S | R | R | S | S | R | S | S | R | R | R | R | S | R | R |
| 3 | ovary | R | R | R | R | R | R | R | S | R | R | R | S | R | R | R | R | R | R | R |
| 3 | ovary | S | S | R | R | S | R | R | R | S | I | I | S | R | I | R | I | S | R | R |
| 3 | ovary | S | S | R | R | S | R | R | S | I | I | S | S | R | I | R | R | S | R | R |
AMC—amoxicillin; APM—ampicillin; AMX—amoxicillin/clavulanate; CAZ—ceftazidim; CEZ—cefazolin; CMP—chloramphenicol; COL—colistin; COX—cefoxitin; CTX—cefotaxim; ENR—enrofloxacin; GEN—gentamicin; IMP—imipenem; NAL—nalidixic acid; NEO—neomycin; SMO—sulfamethoxazole; STR—streptomycin; T/S—trimethoprim/sulfamethozaxole; TET—tetracycline; TRP—trimethoprim.
Figure 2Percentage proportion of E. coli resistance presented as mean value by comparing the isolates based on their isolation site (total numbers are given in brackets). Isolates from the heart, liver, and lungs were allocated to group 1, and isolates from ovaries and oviducts to group 2.
Figure 3Number of antimicrobial substances to which E. coli isolates were resistant, shown in relation to the age of birds (S1 = sampling point 1, age ~17 weeks; S2 = sampling point 2, age ~38 weeks; S3 = sampling point 3, age ~74 weeks). The mean number of antimicrobials to which E. coli isolates were resistant was 8.38 for S1, 10.04 for S2, and 9.87 for S3.